Vanguard Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $24.8K | Hold |
|
|||||
|
2023
Q2 | $25.4K | Sell |
|
|||||
|
2023
Q1 | $74.5K | Sell |
|
|||||
|
2022
Q4 | $140K | Sell |
|
|||||
|
2022
Q3 | $181K | Sell |
|
|||||
|
2022
Q2 | $530K | Hold |
|
|||||
|
2022
Q1 | $582K | Hold |
|
|||||
|
2021
Q4 | $737K | Sell |
|
|||||
|
2021
Q3 | $1.29M | Buy |
|
|||||
|
2021
Q2 | $1.33M | Hold |
|
|||||
|
2021
Q1 | $1.47M | Hold |
|
|||||
|
2020
Q4 | $1.57M | Sell |
|
|||||
|
2020
Q3 | $2.01M | Buy |
|
|||||
|
2020
Q2 | $1.62M | Buy |
|
|||||
|
2020
Q1 | $305K | Buy |
|
|||||
|
2019
Q4 | $260K | Hold |
|
|||||
|
2019
Q3 | $143K | Buy |
|
|||||
|
2019
Q2 | $114K | Sell |
|
|||||
|
2019
Q1 | $552K | Buy |
|
|||||
|
2018
Q4 | $383K | Sell |
|
|||||
|
2018
Q3 | $1.17M | Buy |
|
|||||
|
2018
Q2 | $1.16M | Sell |
|
|||||
|
2018
Q1 | $1.85M | Sell |
|
|||||
|
2017
Q4 | $1.85M | Buy |
|
|||||
|
2017
Q3 | $2.04M | Buy |
|
|||||
|
2017
Q2 | $2.49M | Buy |
|
|||||
|
2017
Q1 | $2.77M | Buy |
|
|||||
|
2016
Q4 | $2.86M | Buy |
|
|||||
|
2016
Q3 | $4.01M | Sell |
|
|||||
|
2016
Q2 | $2.36M | Sell |
|
|||||
|
2016
Q1 | $4.58M | Buy |
|
|||||
|
2015
Q4 | $6.44M | Buy |
|
|||||
|
2015
Q3 | $10.9M | Buy |
|
|||||
|
2015
Q2 | $7.36M | Buy |
|
|||||
|
2015
Q1 | $7.18M | Buy |
|
|||||
|
2014
Q4 | $7.96M | Buy |
|
|||||
|
2014
Q3 | $5.44M | Sell |
|
|||||
|
2014
Q2 | $6.24M | Buy |
|
|||||
|
2014
Q1 | $7.54M | Buy |
|
|||||
|
2013
Q4 | $8.15M | Buy |
|
|||||
|
2013
Q3 | $10.1M | Buy |
|
|||||
|
2013
Q2 | $8.35M | Buy |
|